Advertisement

Topics

Sphere Fluidics collaborates with Peak Analysis and Automation to increase throughput in antibody discovery and cell line development

10:29 EST 15 Jan 2019 | Zyme Communications

PAA’s S-LAB micro-plate handling capability will be integrated with Sphere Fluidics’ Cyto-Mine Single Cell Analysis System

Cambridge and Farnborough, UK, 15 January 2019: Sphere Fluidics, a company commercializing single cell analysis systems underpinned by its patented picodroplet technology, and Peak Analysis and Automation (PAA), a leader in the industry for the design and manufacture of automated laboratory equipment, will collaborate to offer automated micro-plate handling capabilities for single cell analysis. PAA's S-LAB™ plate handler will be integrated with Sphere Fluidics’ Cyto-Mine® Single Cell Analysis System to help increase throughput in antibody discovery and cell line development.

Sphere Fluidics’ Cyto-Mine is an automated platform which combines single cell screening, sorting, isolation and clone verification, alleviating the need for separate instruments. Its application programming interface (API), introduced as part of the updated Cyto-Mine Studio Software Suite in 2018, enables easy communication with PAA’s innovative S-LAB automated plate handler. The integration of micro-plate handling with the Cyto-Mine will help to reduce hands-on intervention to further streamline biopharmaceutical workflows.

Dr Frank Craig, CEO, Sphere Fluidics, commented: “Our Cyto-Mine is compatible with 96- and 384-well microtiter plates, providing a high-throughput platform for single cell analysis. By combining this with the easy-to-use automated plate reader from Peak Analysis and Automation we will be able to offer improved throughput capabilities to help reduce timelines in biotherapeutic discovery and cell-line development.”

Dr Malcolm Crook, Technical Director, Peak Analysis and Automation, said: “Our small, affordable plate handler with the reliability of a robotic arm will offer users of Sphere Fluidics’ award-winning Cyto-Mine system a simple and flexible solution to further improve workflows and reduce costs associated with a more labor-intensive approach.”

Cyto-Mine will be on display in Washington, DC at SLAS 2019 from 2nd to 6th February 2019 (Booth #1655 and #1429).

For further information about Sphere Fluidics and Cyto-Mine, please visit:

https://www.spherefluidics.com/products/integrated-systems/cyto-mine/

For further information about PAA’s lab automation systems, please visit: https://www.paa-automation.com/products/automated-platehandlers/

About Sphere Fluidics www.spherefluidics.com

Sphere Fluidics develops and manufactures single cell analysis and monoclonality assurance systems for biotherapeutic discovery and development.

Sphere Fluidics’ Cyto-Mine® System integrates selective screening of tens of millions of single cells, sorting, isolation and clone verification into a single automated platform to streamline workflows, reduce costs, improve throughput and enable high-value clones to be captured in a single run. Cyto-Mine® is underpinned by the Company’s patented picodroplet technology.

Sphere Fluidics is located in Babraham, Cambridgeshire (UK) and Monmouth Junction, New Jersey (USA). The Company has also internationalized its business via a global network of distributors.

About Peak Analysis and Automation www.paa-automation.com

Peak Analysis & Automation (PAA) provides state-of-the-art automation technology to the pharmaceutical and biotechnology industries. The company offers a complete design and build service for laboratory automation, including the manufacture and supply number of standard products such as laboratory robots, automated plate handlers, automation software and integrated laboratory workcells.

PAA is located in Farnborough, Hampshire (UK) and Colorado Springs, Colorado (USA)

E: info@paa-automation.com: W: www.paa-automation.com; Twitter: @paautomation

For further information please contact: Sphere Fluidics Dr Zoe Nilsson, Global Product Marketing Manager Tel: +44 (0)1223 804210 Email: zoe.nilsson@spherefluidics.com Peak Analysis and Automation Caroline Buggisch, Marketing Manager Tel: +44 (0)1252 373000 Email: caroline.buggisch@paa-automation.com Zyme Communications Dr Michelle Ricketts Tel: +44 (0)778 9053 885 Email: michelle.ricketts@zymecommunications.com NEXT ARTICLE

More From BioPortfolio on "Sphere Fluidics collaborates with Peak Analysis and Automation to increase throughput in antibody discovery and cell line development "

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...